ANZUP 2017 Interviews - David Quinn
David Quinn discusses the KEYNOTE-045 trial on th…
An episode of the Talking Urology Podcast podcast, hosted by Talking Urology, titled "ANZUP 2017 Interviews - David Quinn" was published on November 29, 2017 and runs 16 minutes.
November 29, 2017 ·16m · Talking Urology Podcast
Summary
David Quinn discusses the KEYNOTE-045 trial on the benefits of pembrolizumab in second line treatment of advanced bladder cancer
Episode Description
Similar Episodes
Apr 9, 2026 ·35m
Apr 9, 2026 ·49m
Apr 6, 2026 ·14m
Apr 2, 2026 ·52m
Apr 1, 2026 ·41m
Apr 1, 2026 ·28m